ArticleJournal of medical imaging (Bellingham, Wash.)2025
Glo-In-One-v2: holistic identification of glomerular cells, tissues, and lesions in human and mouse histopathology.
Article in Journal of medical imaging (Bellingham, Wash.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- GloPath: An Entity-Centric Foundation Model for Glomerular Lesion Assessment and Clinicopathological Insights.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Glomeruli detection and classification in histopathological images using deep learning semantic segmentation.BMC medical imaging · 2026Article
- Artificial intelligence in membranous nephropathy: transforming clinical management toward precision medicine.Frontiers in medicine · 2026Review
- How Close Are We? Limitations and Progress of AI Models in Banff Lesion Scoring.Proceedings of SPIE--the International Society for Optical Engineering · 2026Article
- Glo-VLMs: Leveraging Vision-Language Models for Fine-Grained Diseased Glomerulus Classification.Proceedings of SPIE--the International Society for Optical Engineering · 2026Article
- The problem of segmenting global glomerulosclerosis in gigapixel histopathological images: the borderless glomeruli.BMC nephrology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Purpose: Segmenting intraglomerular tissue and glomerular lesions traditionally depends on detailed morphological evaluations by expert nephropathologists, a labor-intensive process susceptible to interobserver variability. Our group previously developed the Glo-In-One toolkit for integrated glomerulus detection and segmentation. We leverage the Glo-In-One toolkit to version 2 (Glo-In-One-v2), which adds fine-grained segmentation capabilities. We curated 14 distinct labels spanning tissue regions, cells, and lesions across 23,529 annotated glomeruli from human and mouse histopathology data. To our knowledge, this dataset is among the largest of its kind to date. Approach: We present a single dynamic-head deep learning architecture for segmenting 14 classes within partially labeled images from human and mouse kidney pathology. The model was trained on data derived from 368 annotated kidney whole-slide images with five key intraglomerular tissue types and nine glomerular lesion types. Results: The glomerulus segmentation model achieved a decent performance compared with baselines and achieved a 76.5% average Dice similarity coefficient. In addition, transfer learning from rodent to human for the glomerular lesion segmentation model has enhanced the average segmentation accuracy across different types of lesions by more than 3%, as measured by Dice scores. Conclusions: We introduce a convolutional neural network for multiclass segmentation of intraglomerular tissue and lesions. The Glo-In-One-v2 model and pretrained weight are publicly available at https://github.com/hrlblab/Glo-In-One_v2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.